Page last updated: 2024-08-21

quinazolines and azd 1480

quinazolines has been researched along with azd 1480 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, M; Gore, JC; Halliday, J; Huszar, D; Lawson, D; Loveless, ME; Nadella, MV; Reimer, C; Waterton, JC; Yankeelov, TE1
de Groot, J; Fuller, G; Heimberger, AB; Kong, LY; Liang, J; Piao, Y; Qiao, W; Wei, J1
Cartron, PF; Cheray, M; Nadaradjane, A; Pacaud, R; Vallette, FM1

Other Studies

3 other study(ies) available for quinazolines and azd 1480

ArticleYear
Comparisons of the efficacy of a Jak1/2 inhibitor (AZD1480) with a VEGF signaling inhibitor (cediranib) and sham treatments in mouse tumors using DCE-MRI, DW-MRI, and histology.
    Neoplasia (New York, N.Y.), 2012, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Janus Kinase 1; Janus Kinase 2; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasms, Experimental; Pyrazoles; Pyrimidines; Quinazolines; Xenograft Model Antitumor Assays

2012
Modulating antiangiogenic resistance by inhibiting the signal transducer and activator of transcription 3 pathway in glioblastoma.
    Oncotarget, 2012, Volume: 3, Issue:9

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; Drug Interactions; Female; Glioblastoma; Humans; Immunohistochemistry; Intermediate Filament Proteins; Macrophages; Mice; Mice, Inbred C57BL; Mice, Nude; Nerve Tissue Proteins; Nestin; Pyrazoles; Pyrimidines; Quinazolines; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2012
Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy.
    Theranostics, 2015, Volume: 5, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Dacarbazine; Female; Glioblastoma; Histones; Humans; Indoles; Male; Middle Aged; Organophosphates; Phosphorylation; Prognosis; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; Quinazolines; Temozolomide

2015